This information is intended only for healthcare professionals resident in the United Kingdom

Prescribing Information (PI) for Cibinqo® (abrocitinib) Great Britain (GB) and Northern Ireland (NI)​​​​​​​​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Cibinqo (abrocitinib) 50mg tablets - PI for GB
  • Cibinqo (abrocitinib) 100mg tablets - PI for GB
  • Cibinqo (abrocitinib) 200mg tablets - PI for GB

Northern Ireland

  • Cibinqo (abrocitinib) 50mg, 100mg and 200mg Tablets - PI for NI

Cibinqo (abrocitinib) 50mg tablets - PI for GB

Cibinqo (abrocitinib) 100mg tablets - PI for GB

Cibinqo (abrocitinib) 200mg tablets - PI for GB

Cibinqo (abrocitinib) 50mg, 100mg and 200mg Tablets - PI for NI

PP-CIB-GBR-0307 July 2022